Concepedia

Nanda Aryal

NA

4

Publications

188

Citations

4

H-Index

2019

Active since

Affiliations

The University of Sydney(Current)

Princess Margaret Cancer Centre

Pomeranian Medical University

Arcagy Gineco

European Institute of Oncology

Nanda Aryal is an author at The University of Sydney specializing in oncology, cancer therapeutics, and ovarian cancer.

ORCID

Top concepts

Publications per year

2019–2024

4

Publications

4

Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial

Jean‐Sébastien Frenel, J.W. Kim, Nanda Aryal et al. · Annals of Oncology · 2022 · 140 citations

, , +8

Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 study

Fabian Trillsch, Sven Mahner, Beyhan Ataseven et al. · Gynecologic Oncology · 2022 · 22 citations

, , +6

Drug–Drug Interactions and Actual Harm to Hospitalized Patients: A Multicentre Study Examining the Prevalence Pre- and Post-Electronic Medication System Implementation

Ling Li, Jannah Baker, Renee Quirk et al. · Drug Safety · 2024 · 16 citations · Full text

Fitting the Bartlett–Lewis rainfall model using Approximate Bayesian Computation

Nanda Aryal, Owen Jones · Mathematics and Computers in Simulation · 2019 · 10 citations

, , +5

Rows per page

1–4 of 4